GLP-1 Drugs May Work Differently in Women
(MedPage Today) -- Women lost more weight than men while using GLP-1 receptor agonists, a systematic review and meta-analysis of ...
Tag: Drugs
GLP-1 Drugs Tied to Unexpected Migraine Benefits
(MedPage Today) -- Chronic migraine patients who used GLP-1 receptor agonists to treat conditions like obesity or diabetes had fewer ...
Ileal Crohn’s Disease; Infections Post-Colorectal Surgery; SGLT2 Drugs and Cirrhosis
(MedPage Today) -- Ten-year follow-up from the randomized LIR!C trial favored ileocecal resection over infliximab (Remicade) for achieving sustained clinical ...
FDA proposes new system for approving customised drugs and therapies for rare diseases
The Food and Drug Administration is proposing a system for approving customised drugs and medical treatments for patients with rare ...
Massive study finds most statin side effects aren’t caused by the drugs
A massive review of 23 randomized trials found that statins do not cause the vast majority of side effects listed ...
Blockbuster weight loss drugs like Ozempic deliver big results but face big questions
Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), ...
Budget 2026 slashes customs duties on 17 cancer drugs, eases baggage rules
FM Sitharaman also announced that the advance ruling will be binding on customs authorities for five years, up from three ...
GLP-1 Drugs and Liver Complications; Tracking Endoscopists’ Eyes; Peppermint for IBS
(MedPage Today) -- GLP-1 receptor agonists and SGLT2 inhibitors were associated with lower risks for liver-related events and hepatocellular carcinoma ...
Botox, Trulicity, and 13 Other Drugs Selected for Medicare Price Negotiation
(MedPage Today) -- The popular type 2 diabetes drug dulaglutide (Trulicity), botulinum toxin (Botox), and drugs to treat psoriatic arthritis, ...
Health Ministry notifies amendments to New Drugs and Clinical Trials Rules, 2019
The move is to simplify regulatory processes, reduce approval time, and to enable faster conduct of clinical research in pharmaceutical ...